Corient Private Wealth’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Corient Private Wealth's ELV Position: Q1 2026 in Review
Corient Private Wealth reduced its Elevance Health (ELV) stake by 55% in Q1 2026, selling an estimated $27.7M and leaving 70,218 shares worth $20.5M. The position accounts for 0.03% of the portfolio, ranked #398.
Corient Private Wealth first reported a position in ELV in Q4 2022 and has held it in 14 quarters since. The position peaked at $46.8M in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Corient Private Wealth held 70,218 shares of Elevance Health worth $20.5M as of Q1 2026.
- Corient Private Wealth sold 84,398 Elevance Health shares in Q1 2026, an estimated $27.7M.
- Elevance Health made up 0.03% of Corient Private Wealth's portfolio in Q1 2026, its #398 holding.
- Corient Private Wealth first reported a position in Elevance Health in Q4 2022 and has held it in 14 quarters since.
- Corient Private Wealth's Elevance Health position peaked at $46.8M in Q4 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.